| 2/22/2006 | CV | IVAX starts change-of-control tender for 4.5% convertibles
|
| 1/9/2006 | BTCV | IVAX buys $50.499 million of tendered 4.5% convertibles
|
| 1/4/2006 | CV | Market Commentary: Convertible market sees broad-based gains, GM, Ford lift; airlines better, Calpine adds points
|
| 1/3/2006 | BTCV | Teva does not exercise fundamental change option for IVAX 1.5% convertibles due 2025
|
| 12/6/2005 | BTCV | Teva does not expect to choose fundamental change option for IVAX 1.5% convertibles due 2025
|
| 11/28/2005 | CV | Market Commentary: Airline, retail convertibles attract bids; Platinum Underwriters launches $150 million preferreds
|
| 11/23/2005 | BTCV | IVAX tenders for 4.5% convertibles, 1.5% convertibles due 2024, 2025 to become convertible
|
| 8/3/2005 | CV | Market Commentary: Human Genome to price $230 million of convertibles; Reebok paper jumps on buyout news
|
| 7/25/2005 | CV | Market Commentary: CSK on tap; L-3, Barnes, Manor Care, FTI, Conseco later in week; Ivax in quandary on Teva merger
|
| 7/25/2005 | BTCV | Ivax's notes may end up with all-cash payment under acquisition by Teva, Merrill report says
|
| 7/22/2005 | CV | Market Commentary: Cheniere deal, earnings boost convertible market's energy names; biotech eases slightly
|
| 7/15/2005 | CV | Market Commentary: Chiron drops as convertibles market trades mostly flat to lower; but CV Therapeutics, Isis gain
|
| 7/8/2005 | CV | Market Commentary: Biotechs, chips lead convertibles mostly higher; Charming Shoppes, Henry Schein trade higher
|
| 5/25/2005 | CV | Market Commentary: Ford buying continues on Visteon bailout, GM issues join in; Calpine issues rise on pumped up debt cuts
|
| 5/10/2005 | CV | Market Commentary: GM, Ford sputter but drive volume in Tower Auto, American Axle; TOP Tankers delayed
|
| 5/4/2005 | CV | New Issue: Ivax sells $350 million convertible at 1.5%, up 18%; reoffered at 98
|
| 5/4/2005 | CV | Market Commentary: GM convertibles soar on Kerkorian news; Lazard at bat; Ivax at 98.5; American Tower buyers seen
|
| 5/3/2005 | CV | Ivax $350 million overnighter talked at 1.5%, up 18%; reoffered by bookrunner Merrill at 99-100
|
| 5/3/2005 | CV | Market Commentary: Primus plummets again; Charter up a touch; Ivax deal surfaces; TOP Tankers sweetens terms
|
| 4/15/2005 | CV | Market Commentary: GM, Ford selling accelerates; El Paso, Calpine, NRG plunge; Ivax, Teva lose; Lucent, Tyco unwound
|
| 3/15/2005 | CV | Market Commentary: Central Parking up; Whole Foods off as Wild Oats rises; Ivax better, Curagen slides; Leucadia easier
|
| 2/23/2005 | CV | IVAX exchanges 99.75% of 1.5% convertibles
|
| 2/22/2005 | CV | Market Commentary: Level 3 converts rise on private deal; UniSource, Allied Waste deals emerge; Par, Ivax, Teva up
|
| 2/14/2005 | CV | IVAX extends exchange for 1.5% convertibles
|
| 1/20/2005 | CV | IVAX starts exchange for 1.5% convertibles
|
| 12/22/2004 | CV | IVAX greenshoe exercised, raising convertibles to $333 million
|
| 12/17/2004 | CV | New Issue: Ivax sells $283 million convertible at 1.875%, up 31.5%, reoffered at 98.5
|
| 12/17/2004 | CV | Market Commentary: IVAX reoffered at 98.5; BearingPoint up to 101.25; Charter up on M&A talk; PSEG soars on buyout buzz
|
| 12/17/2004 | CV | IVAX to buy back $250 million 41/2% convertibles with 1 7/8% note sale proceeds
|
| 11/2/2004 | CV | Market Commentary: Deal flow seen improving after election; Durect eyed; Delta 8s ease; Ivax off again
|
| 9/21/2004 | CV | Market Commentary: CenterPoint convertibles dip on lower cost recovery ruling; Calpine issues continue slide
|
| 8/31/2004 | CV | New Issue: Morgan Stanley prices $8.97 million 9% Sparqs exchangeable for IVAX
|
| 8/30/2004 | CV | New Issue: Goldman prices $5.59 million notes exchangeable for IVAX
|
| 8/30/2004 | CV | Market Commentary: LNR convertible leveled by $1.9 billion cash takeover; United Rentals falls on SEC inquiry
|
| 5/20/2004 | CV | Market Commentary: Airline paper cheapens further, despite rise in stocks; Guilford shelf uplifts holders of rich bonds
|
| 3/26/2004 | CV | IVAX calls 5.5% convertibles
|
| 3/10/2004 | CV | Market Commentary: Level 3 falls on Global Crossing meltdown; Marriott offered at par in gray market; biotechs plummet
|
| 3/3/2004 | CV | IVAX greenshoe exercised, raising convertibles to $400 million
|
| 3/1/2004 | CV | New Issue: Goldman Sachs prices $5.5 million 5.25% notes exchangeable for IVAX
|
| 2/27/2004 | CV | New Issue: Ivax sells $350 million convertible at 1.5%, up 26%
|
| 2/27/2004 | CV | Market Commentary: Veritas DGC, Ivax hover at par; Pride plunges on loss related to deepwater rigs; New Century up
|
| 2/26/2004 | CV | Ivax $350 million overnight convertible talked at 1.0-1.5% yield, 25-30% premium
|
| 2/26/2004 | CV | Market Commentary: Calpine slides on earnings; Toys R Us mandatory soars on stock upgrade; MGI up 0.25 point
|
| 12/5/2002 | CV | Salomon adds Triquint, Ivax as Clear Channel, NDCHealth disappear
|
| 5/17/2002 | CV | Market Commentary: LifePoint gains in hungry market; El Paso drops on "bad" news
|
| 4/10/2002 | CV | Deutsche analysts say credit work provides insight for generic drug picks
|
| 4/5/2002 | CV | Market Commentary: Adelphia gains on hiring advisors; Getty Images soars on EPS revision; Genentech falls
|
| 10/26/2001 | CV | Market Commentary: Convertible market surges with $2.6 bln of new paper
|
| 10/24/2001 | CV | UBS convertible analysts: stocks may not recover soon, so play defensive
|
| 10/22/2001 | CV | Market Commentary: Convertibles gain with stocks, new deals keep coming
|
